About Editorial team of BIPNs

Main team of content of bipns.com. Any type of content should be approved by us.
1 12, 2025

Bitcoin price BTC USD crash alert: Bitcoin price crash forecast: Why BTC USD may fall below $50,000 by 2026 – analyst warns of market reset, S&P 500 drop, and gold surge

By |2025-12-01T22:37:02+02:00December 1, 2025|Crypto News, News|0 Comments

Bitcoin price crash: A crypto analyst known as ‘NoLimit’ on social media X has issued a dramatic forecast, predicting that Bitcoin’s price could drop below $50,000 by 2026, a decline of more than 42% from its current value above $86,000, as per a report.

Bitcoin Price Crash Will Trigger a Broader Market Reset

Despite the projected slump, he claims that 2026 could become a historic year for investors who stay calm and prepare, potentially marking one of the largest wealth-transfer events in over a decade, as per a Tradingview report.

NoLimit says that as Bitcoin falls to projected lows, the broader market could undergo a deep structural reset. He expects this correction to impact not only cryptocurrencies but also traditional financial assets.

ALSO READ: Why Bitcoin price (BTC USD) crashed today: December crypto market sell-off reasons explained

US Assets vs Liabilities: Growing Gap Signals Economic Risk

The analyst highlights the growing gap between US assets and liabilities as a warning signal. According to his chart, liabilities have climbed from about $30 trillion in 2016 to over $60 trillion in 2025, while assets have grown more slowly. This widening imbalance, he argues, could trigger broader market corrections.

S&P 500 and Stock Market Could Face Severe Corrections in 2026

During the anticipated market reset, NoLimit predicts the S&P 500 could drop up to 40%, with individual companies potentially losing 50% to 98% of their value, echoing the extreme declines seen during the dot-com crash in 2001.

ALSO READ: Bitcoin price today drops to $85,000: Why Michael Saylor predicts BTC USD could reach $21 million in 21 years — is it possible?

Gold Price Prediction 2026: Could Gold Surge to $6,500

While Bitcoin may fall, the analyst forecasts gold could rise to $6,500, a gain of more than 53% from its current price of around $4,233.

Bank Collapse Risks: What Investors Need to Know

NoLimit also warns that several banks may collapse in 2026, citing high debt levels, overextended government and corporate loans, and $1.2 trillion in commercial real estate loans set to mature between 2025 and 2026.

How Investors Can Prepare for 2026 Crypto and Market Volatility

The analyst emphasizes that investors who preserve liquidity and strategically position themselves during market lows are likely to benefit the most from the projected changes.

FAQs

What could happen to the stock market in 2026?
The S&P 500 could drop up to 40%, with some companies losing 50–98% of value.

What is NoLimit predicting for Bitcoin in 2026?

He predicts BTC could drop below $50,000, a 42%+ decline from today.

Source link

1 12, 2025

Información comprobada sobre el cáncer pulmonar de inicio temprano

By |2025-12-01T22:17:14+02:00December 1, 2025|Fitness News, News|0 Comments

English

Los casos de personas que no fuman que desarrollan cáncer pulmonar han aumentado en los últimos 25 años, y simultáneamente, han estado ocurriendo más casos de cáncer pulmonar de inicio temprano (antes de cumplir 50 años).

HealthyWomen habló con Mohana Roy, M.D., oncóloga médica y profesora clínica adjunta de la facultad de medicina de la Universidad de Stanford, acerca de por qué están aumentando los cánceres pulmonares de inicio temprano y qué están haciendo los expertos al respecto.

¿Sabemos por qué los diagnósticos de cáncer pulmonar de personas jóvenes están aumentando, particularmente de personas que no fuman?

No sabemos por qué. Parte de eso tiene que ver con mejoras de la imagenología, cosas tales como los rayos equis y las TC. Ahora podemos ver los nódulos pulmonares, áreas diminutas de tejido denso que son más pequeños que el tamaño de un guisante. Creo que solo estamos detectando más cánceres por las imágenes que ahora podemos tener.

En lo que se refiere a los cánceres pulmonares de personas que no fuman, creo que eso ha sido una de las cosas más difíciles de la medicina. Obviamente pensamos que el cáncer es una enfermedad que se asocia al cigarrillo (no usamos realmente la palabra “causar”), pero ahora estamos identificando cada vez más casos de cáncer pulmonar vinculados con mutaciones.

Las mutaciones son cambios genéticos que ocurren en tu ADN, es decir, cambios que ocurren dentro del cuerpo, no cosas que se heredan. Muchas investigaciones sugieren que las mutaciones son la razón por la que estamos viendo cada vez más cánceres pulmonares en personas que no fuman, pero todavía no sabemos por qué algunas personas desarrollan estas mutaciones.

Lee: ¿Por qué personas que no fuman están desarrollando cáncer pulmonar? >>

¿Se ven ciertas mutaciones más frecuentemente en cánceres pulmonares de inicio temprano de personas más jóvenes?

Si, así es. La mutación del receptor del factor de crecimiento epidérmico o RFCE es la mutación conocida más frecuente de personas que no fuman. Las otras dos que vemos más a menudo, aunque son relativamente infrecuentes, si se toman en cuenta a todos los cánceres pulmonares, son ALK y ROS1. Esas son las tres mutaciones principales que más vemos en personas que no fuman y también en pacientes más jóvenes.

Realmente estamos aprendiendo la composición del diagrama de sectores, es decir, si ves al diagrama de sectores de todos los cánceres pulmonares, solo solíamos conocer esas tres mutaciones, que son sectores pequeños porque son relativamente infrecuentes. Ahora estamos encontrando cada vez más mutaciones que se asocian al cáncer pulmonar, así que el diagrama cada vez tiene más elementos. Pero RFCE, ALK y ROS1 son todavía las más comunes.

¿Qué tipo de tratamientos se usan más frecuentemente para cánceres con mutaciones?

Si se encuentra una de estas mutaciones, usualmente se trata con píldoras, lo cual es realmente infrecuente para cánceres pulmonares. El cáncer pulmonar casi siempre requiere quimioterapia. Hemos hecho eso por muchísimos años. Pero para algunas de estas mutaciones, ahora podemos omitir la quimioterapia porque tenemos evidencia científica que indica que las píldoras de hecho son más efectivas que la quimioterapia. Esta fue una revelación enorme en nuestro campo y ha sido el estándar por aproximadamente 15 años.

Estas píldoras son un tipo de tratamiento dirigido. Esto significa que se diseñaron para atacar selectivamente las células cancerosas que tienen algo malo y, con suerte, se evita que se propaguen. Muchos de estos tratamientos se denominan inhibidores de las tirosina-cinasas. La tirosina-cinasa es una de las enzimas que permiten que el cáncer se propague y estas píldoras la bloquean.

No todos los pacientes con mutaciones recibirán solamente píldoras. Estamos descubriendo que para muchos pacientes que tienen la mutación RFCE y cáncer de etapa 4 o metastásico, que es cuando el cáncer ya se ha propagado y se considera incurable, podría ser beneficioso usar quimioterapia y las píldoras.

Lee: Tratamiento contra el cáncer pulmonar: Siguientes pasos después del diagnóstico >>

¿Hay consideraciones adicionales para los efectos colaterales del tratamiento y para los desenlaces clínicos de adultos jóvenes con cáncer pulmonar?

Pienso que la fertilidad es algo que consideramos mucho más. No siempre hemos tenido el sistema más robusto en la mayoría de centros contra el cáncer porque, lógicamente, estamos acostumbrados a atender a personas mayores. Pero de hecho creo que hay mucha concientización a nivel nacional acerca de la necesidad de conversaciones sobre la fertilidad.

En lo que se refiere a las píldoras de tratamientos dirigidos, hay muy poca información sobre cómo el tratamiento afecta la fertilidad. Pero, en general, las personas no deberían estar embarazadas si toman estas píldoras, así que hablamos de eso anticipadamente.

Muchos de estos tratamientos dirigidos causan un nivel considerable de sarpullido y problemas de la piel y eso afecta la imagen corporal y también puede ser doloroso. Tenemos un muy buen equipo en Stanford a quienes nos referimos como dermatólogos solidarios que tienen el trabajo de ayudarnos a controlar los efectos colaterales de estas píldoras. Facilitamos muchas cremas y tratamientos para asegurarnos que se controlen los sarpullidos y no afecten la vida cotidiana de las personas.

Usualmente la pérdida de cabello es mínima, incluso con las quimioterapias que usamos para el cáncer pulmonar. Siempre digo a mis pacientes que mi meta es que lo que ocurre en la clínica es confidencial, de tal forma que si van al supermercado después de eso, nadie sabrá que acaban de tener un tratamiento contra el cáncer.

¿Hay diferencias de los síntomas y de las tasas de supervivencia entre los cánceres pulmonares de personas más jóvenes y de personas mayores?

En general, la supervivencia de cáncer pulmonar es muy mala y definitivamente está por debajo de muchos otros cánceres en lo que se refiere al tiempo que las personas viven después del diagnóstico. Pienso que para personas más jóvenes es simplemente más difícil porque nuestros pulmones son muy resilientes. A lo que me refiero es que nuestros pulmones pueden esconder cosas realmente bien, especialmente si alguien es joven, no fuma y no tiene ningún otro trastorno pulmonar.

Alguien podría tener desafortunadamente una masa considerablemente grande en su pulmón y no tener síntomas. Una de las cosas más espeluznantes es que tendemos a encontrar más cánceres de etapa 4 en personas jóvenes. Esto no es necesariamente un dato estadístico. Simplemente es lo que he visto.

Para pacientes con mutaciones, la tasa de supervivencia es generalmente mejor. Por ejemplo, ahora tenemos datos de que personas con la mutación ALK viven con cáncer pulmonar incurable por más de cinco años. Sé que eso no parece bastante, pero eso no se solía escuchar para cánceres pulmonares que se han propagado, así que hemos progresado mucho.

Este recurso educativo se preparó con el apoyo de Merck.

From Your Site Articles

Related Articles Around the Web



Source link

1 12, 2025

Why green tea delivers the strongest health benefits

By |2025-12-01T20:42:08+02:00December 1, 2025|Dietary Supplements News, News|0 Comments


A major scientific review uncovers how a simple cup of brewed tea can deliver real health gains, from heart protection to sharper cognition. However, it also warns consumers about the risks hiding in supplements and processed tea drinks.

Study: Beneficial health effects and possible health concerns of tea consumption: a review. Image credit: Pixel-Shot/Shutterstock.com

In a recent study published in Beverage Plant Research, researchers examined the health effects of tea consumption. They concluded that tea is broadly safe and beneficial, particularly when consumed as traditional brewed tea. Green tea exhibits the most consistent benefits, although black and other teas also offer advantages.

A globally popular beverage

Tea made from Camellia sinensis is among the most widely consumed beverages worldwide, with black and green teas accounting for the majority of production. Modern research has focused on identifying the active compounds that contribute to these effects, particularly tea polyphenols, mainly catechins in green tea and theaflavins and thearubigins in black tea.

Green tea is minimally fermented, preserving high levels of catechins, while black tea undergoes extensive oxidation that converts catechins into complex polyphenols. Caffeine and the amino acid theanine also contribute to tea’s physiological actions.

Large cohort studies have linked tea consumption to lower cardiovascular mortality, a reduced risk of certain cancers, and a decreased incidence of type 2 diabetes. Laboratory studies provide mechanisms related to antioxidant activity, improved lipid metabolism, and modulation of signaling pathways. However, translating findings from cell and animal studies to humans is challenging due to differences in bioavailability, dosage, and physiology.

Heart disease, cancer, and mortality

The strongest and most consistent evidence links tea consumption, particularly green tea, to a reduced risk of cardiovascular disease (CVD). Large cohort studies demonstrate that drinking around 1.5 to 3 cups per day lowers CVD and all-cause mortality, with cardiovascular benefits remaining significant even at higher intakes. However, diminishing returns are observed for overall mortality.

Benefits observed in Japan, China, and the UK suggest that both green and black tea contribute to improved vascular health. Mechanistic studies suggest that polyphenols reduce low-density lipoprotein (LDL) cholesterol, enhance endothelial function, lower blood pressure, and exhibit antioxidant and anti-inflammatory effects.

Evidence for cancer prevention is more mixed: while animal studies are robust, human findings vary by cancer type and population. Still, meta-analyses support risk reductions for oral, lung (in women), and colon cancers with regular green tea intake.

Weight management and type 2 diabetes

Green tea and catechin-rich preparations show modest but consistent effects on reducing body weight and fat mass, particularly in overweight individuals. Trials report reductions in LDL cholesterol and oxidative stress after several weeks of consumption.

Cohort studies generally indicate a lower risk of type 2 diabetes with higher tea intake. Yet, contradictory findings exist, most notably from the Shanghai Women’s and Men’s Health Studies, which reported an increased risk of diabetes.

Randomized trials in diabetic patients have not shown improvements in glucose or insulin measures, leaving uncertainty about tea’s role in glycemic control.

Neuroprotection and muscle health during aging

Epidemiological evidence from China and Japan suggests that habitual tea drinking is associated with reduced cognitive decline, improved cognitive performance, and lower biomarkers linked to Alzheimer’s disease. Meta-analyses also find a clear protective association, with the strongest effects observed in adults aged 50 to 69 years. Theanine, a unique component of tea, may contribute to stress-reduction and neurocalming effects, as well as its ability to cross the blood–brain barrier.

Research indicates that catechin-rich extracts can help maintain or increase muscle mass and strength, especially in older adults or individuals with sarcopenia. Human trials have shown improved grip strength and muscle function after supplementation, while animal studies have demonstrated protective effects against disuse-induced muscle loss.

Inflammation, immunity, and disease protection

Green tea consumption is linked to lower uric acid levels, with stronger associations observed in men. Small experimental studies have shown an enhanced excretion of uric acid following the intake of tea or catechins. Tea polyphenols also reduce inflammatory markers and improve markers of oxidative stress, including in individuals with hypertension or chronic kidney disease.

Tea catechins inhibit a wide range of bacteria and viruses. In the oral cavity, catechins can reduce the growth of cariogenic bacteria and improve oral health. Some demonstrate antiviral effects against hepatitis viruses, influenza, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and human papillomavirus (HPV), mainly by blocking viral entry processes. However, most antiviral studies are in vitro and cannot be directly extrapolated to humans.

Different types of tea and tea-based beverages

Although green tea carries the strongest evidence base, Oolong, white, dark, and yellow teas also show potential benefits. Animal studies comparing teas made from the same leaf batches suggest Oolong tea may outperform others in weight control, while white tea may be most effective for lipid reduction. Still, these findings cannot be reliably generalized to humans.

Bottled or bubble teas pose health concerns due to the addition of sugars, sweeteners, and preservatives, which may counteract their natural benefits. Processing and storage also reduce catechin content compared with traditional brewing.

Conclusions

The review highlights strong human evidence for cardiovascular and metabolic benefits of tea, with additional promising effects on cognition, muscle health, inflammation, and microbial activity. A major strength is its reliance on large cohort data supplemented by mechanistic insights.

However, inconsistent findings, especially for diabetes and cancer, and limited human research on non-green teas remain significant limitations. Results from animal and in vitro studies cannot be directly extrapolated to humans.

Despite these gaps, the overall conclusion is that tea is a safe, health-promoting beverage when consumed traditionally. However, high-dose supplements and low-quality commercial products present potential risks that consumers should be aware of. Further high-quality human research is needed across diverse tea types and health outcomes.

Download your PDF copy now!

Journal reference:



Source link

1 12, 2025

Will XRP Finally Reach $5?

By |2025-12-01T20:36:04+02:00December 1, 2025|Crypto News, News|0 Comments

BitcoinWorld

Ripple XRP Price Prediction 2025-2030: Will XRP Finally Reach $5?

Will Ripple’s XRP finally break through and reach the elusive $5 mark? As one of the most watched cryptocurrencies in the market, XRP has experienced dramatic volatility, regulatory challenges, and growing adoption. Investors worldwide are asking the same question: what does the future hold for XRP’s price? In this comprehensive analysis, we’ll explore realistic Ripple XRP price predictions from 2025 through 2030, examining the key factors that could propel XRP to $5 or keep it grounded.

Understanding the Current XRP Market Position

XRP currently ranks among the top cryptocurrencies by market capitalization, but its journey has been anything but smooth. The digital asset serves as the native token for Ripple’s payment network, designed to facilitate fast, low-cost cross-border transactions. Unlike many cryptocurrencies, XRP has established partnerships with financial institutions worldwide, giving it unique utility in the traditional finance sector.

Several factors influence XRP’s price trajectory:

  • Regulatory clarity from the ongoing Ripple SEC lawsuit
  • Adoption by banks and payment providers
  • Overall cryptocurrency market trends
  • Technological developments within the Ripple ecosystem
  • Macroeconomic factors affecting digital assets

The Ripple SEC Lawsuit: A Critical Turning Point

The legal battle between Ripple and the U.S. Securities and Exchange Commission has been the single most significant factor affecting XRP’s price in recent years. The lawsuit, filed in December 2020, alleges that Ripple conducted an unregistered securities offering through XRP sales. The outcome of this case will dramatically impact XRP’s regulatory status and institutional adoption.

Recent developments have been promising for Ripple. In July 2023, a federal judge ruled that XRP is not necessarily a security when sold to retail investors on exchanges. This partial victory provided immediate relief to XRP holders and exchanges that had delisted the token. However, the case continues regarding institutional sales, and a final resolution could provide the regulatory clarity needed for broader adoption.

XRP Price 2025: Short-Term Projections and Realistic Targets

Looking ahead to 2025, several scenarios could unfold for XRP’s price. Most analysts agree that the resolution of the SEC lawsuit will be the primary driver of price movement in this timeframe. If Ripple achieves a favorable settlement or outright victory, we could see renewed institutional interest and exchange listings.

Scenario Price Range Key Drivers
Bullish $2.50 – $3.50 SEC victory, major bank adoption, crypto bull market
Moderate $1.20 – $2.00 Favorable settlement, steady adoption, stable market
Bearish $0.50 – $1.00 Unfavorable ruling, limited adoption, crypto winter

The $5 target for 2025 appears ambitious but not impossible under perfect conditions. This would require not only a complete legal victory for Ripple but also massive institutional adoption and a broader cryptocurrency bull market exceeding previous cycles. More realistically, 2025 might set the stage for XRP’s longer-term growth toward $5.

Will XRP Reach $5? Analyzing the Path Forward

The $5 milestone represents more than a 10x increase from current levels, requiring substantial fundamental changes in XRP’s adoption and utility. Several factors must align for XRP to reach this price point:

  • Mass Institutional Adoption: Widespread use by banks and financial institutions for cross-border payments
  • Regulatory Clarity: Clear, favorable regulations across major markets including the US, EU, and Asia
  • Ecosystem Growth: Expansion of RippleNet and related services increasing XRP utility
  • Market Conditions: Supportive macroeconomic environment for risk assets
  • Technological Advancements: Improvements to the XRP Ledger enhancing scalability and features

Historical patterns suggest that XRP tends to perform exceptionally well during cryptocurrency bull markets, often outperforming Bitcoin in percentage gains during these periods. However, reaching $5 would require XRP to surpass its previous all-time high of approximately $3.84 set in January 2018, adjusted for inflation and market changes.

Cryptocurrency Forecast: XRP’s Position in the Broader Market

XRP exists within a competitive cryptocurrency landscape where Bitcoin and Ethereum dominate market attention and capital. However, XRP’s focus on institutional payments gives it a unique niche. As traditional finance increasingly explores blockchain technology, Ripple’s established relationships with financial institutions could provide a significant advantage.

The growing Central Bank Digital Currency (CBDC) movement presents both opportunities and challenges for XRP. Some analysts believe XRP could serve as a bridge currency between different CBDCs, while others worry that national digital currencies might reduce demand for private alternatives like XRP. Ripple has actively positioned itself as a CBDC partner, developing technology to support central banks in their digital currency initiatives.

Long-Term Ripple XRP Price Prediction: 2026-2030 Outlook

Looking beyond 2025, XRP’s trajectory depends heavily on how the cryptocurrency ecosystem evolves. By 2030, blockchain technology is expected to be more integrated into mainstream finance, potentially benefiting established players like Ripple.

Year Conservative Prediction Moderate Prediction Optimistic Prediction
2026 $1.80 – $2.50 $2.50 – $3.50 $3.50 – $5.00
2027 $2.20 – $3.00 $3.00 – $4.50 $4.50 – $7.00
2028 $2.80 – $4.00 $4.00 – $6.00 $6.00 – $10.00
2029 $3.50 – $5.00 $5.00 – $8.00 $8.00 – $15.00
2030 $4.50 – $6.50 $6.50 – $12.00 $12.00 – $25.00

These predictions assume gradual adoption and favorable regulatory developments. The $5 target becomes increasingly plausible in the later years of this decade, especially under optimistic scenarios where Ripple captures significant market share in cross-border payments.

Risks and Challenges to XRP’s Growth

While the potential for growth exists, investors must consider significant risks:

  • Regulatory Uncertainty: Ongoing and potential future regulatory challenges
  • Competition: Emerging technologies and established competitors in cross-border payments
  • Centralization Concerns: Criticisms regarding Ripple’s control over XRP supply
  • Market Volatility: Cryptocurrency’s inherent price volatility and correlation with Bitcoin
  • Adoption Hurdles: Resistance from traditional financial institutions to adopt new technologies

These factors could delay or prevent XRP from reaching price targets, making diversification essential for cryptocurrency investors.

Actionable Insights for XRP Investors

Based on our analysis, here are practical considerations for those interested in XRP:

  1. Monitor Legal Developments: The SEC lawsuit remains the most immediate price catalyst
  2. Diversify Your Portfolio: Never allocate more to XRP than you can afford to lose
  3. Consider Dollar-Cost Averaging: Regular investments can reduce timing risk
  4. Stay Informed About Adoption: Track Ripple’s partnerships and institutional usage
  5. Prepare for Volatility: XRP has shown extreme price swings in both directions

Frequently Asked Questions

What is Ripple and how is it different from XRP?
Ripple is a technology company that develops payment solutions using blockchain technology. Ripple created the XRP cryptocurrency to facilitate fast, low-cost international transactions on its network. While related, Ripple the company and XRP the cryptocurrency are separate entities.

Who is Brad Garlinghouse and what is his role?
Brad Garlinghouse is the CEO of Ripple Labs. He has been a vocal advocate for cryptocurrency regulation and has led Ripple through its legal challenges with the SEC.

What was the significance of the July 2023 court ruling?
In July 2023, Judge Analisa Torres ruled that XRP is not necessarily a security when sold to retail investors on exchanges. This provided temporary relief but didn’t resolve the entire case regarding institutional sales.

How does XRP’s technology compare to other cryptocurrencies?
The XRP Ledger uses a consensus protocol rather than proof-of-work mining, making it faster and more energy-efficient than Bitcoin. It can settle transactions in 3-5 seconds with minimal fees.

Which companies are partnering with Ripple?
Ripple has partnered with numerous financial institutions including Santander, Standard Chartered, and MoneyGram, though some partnerships have evolved or ended over time.

Conclusion: The Road to $5 and Beyond

XRP’s journey toward $5 represents more than just a price target—it symbolizes the maturation of cryptocurrency as a legitimate financial tool. While the path contains regulatory hurdles, competitive pressures, and market volatility, XRP’s unique position in institutional payments provides a compelling case for long-term growth. The resolution of the SEC lawsuit will likely determine XRP’s trajectory in the coming years, potentially unlocking the institutional adoption needed to reach and sustain higher price levels. Whether XRP reaches $5 by 2025, 2030, or beyond depends on a complex interplay of legal, technological, and market factors that will unfold in the years ahead.

To learn more about the latest cryptocurrency market trends, explore our articles on key developments shaping blockchain adoption, regulatory changes, and institutional investment in digital assets.

This post Ripple XRP Price Prediction 2025-2030: Will XRP Finally Reach $5? first appeared on BitcoinWorld.



Source link

1 12, 2025

Will Trading Turn Bullish? (Chart)

By |2025-12-01T18:47:11+02:00December 1, 2025|Forex News, News|0 Comments

EUR/USD Analysis Summary Today

  • Overall Trend: : Neutral.
  • Support Levels for EUR/USD Today: 1.1555 – 1.1470 – 1.1400
  • Resistance Levels for EUR/USD Today: : 1.1640 – 1.1700 – 1.1770

EUR/USD Trading Signals:

  • Buy EUR/USD from the support level of 1.1510 with a target of 1.1700 and a stop-loss at 1.1450.
  • Sell EUR/USD from the resistance level of 1.1700 with a target of 1.1500 and a stop-loss at 1.1780.

Technical Analysis of EUR/USD Today:

At the end of last week’s trading, the EUR/USD stabilized following the release of the latest Eurozone Consumer Price Index (CPI) data. As announced, inflation is stable across most member states, and falling energy prices may contribute to its gradual decline. Excessive disinflation could eventually prompt the European Central Bank (ECB) to consider further cuts, which would weigh on the Euro, but there is no evidence of this yet. According to licensed currency trading platforms, the Euro/Dollar price is currently stable around the 1.1600 level in the neutral zone at the start of the trading week.

Eurozone Inflation Rate Stabilization

According to the results of the economic calendar data, consumer price pressures in the Eurozone continue to show stability. National data pointed to subdued inflation expectations for November, reinforcing the ECB’s position to keep interest rates unchanged at this month’s meeting. As announced, the annual Consumer Price Index (CPI) in France stabilized at 0.8%. Harmonized inflation in Spain fell slightly to 3.1% from 3.0%, as falling food and transport prices offset some stickier core factors. In Germany, regional data from key states like North Rhine-Westphalia and Bavaria showed little change from the previous national reading of 2.3%.

On the other hand, selling price expectations in the services and manufacturing sectors have recently risen again, and upcoming fiscal stimulus is also expected to lead to new inflationary pressures, at least in certain sectors. In this regard, economists at Standard Chartered reported that their model suggests Eurozone core inflation is aligning with 2.5% for November. Akriti Agarwal, the bank’s European economist, stated that the rising Euro and weaker Spanish data would neutralize the upward effects of producer prices in other regions.

When is the euro trading bullish?

Based on the daily chart above, the current trading range for the EUR/USD is neutral. This is confirmed by the 14-day Relative Strength Index (RSI) holding around a reading of 52, slightly above the neutral line. Simultaneously, the MACD indicator lines are preparing to turn upward pending stronger positive catalysts. A bullish turn for the Euro/Dollar requires a move toward the resistance levels of 1.1685, 1.1770, and 1.1820, respectively. Conversely, the bearish scenario for the Euro/Dollar will remain the most likely as long as it stabilizes around and below the psychological support level of 1.1500.

Today’s EUR/USD trading session will react to the release of the Manufacturing Purchasing Managers’ Index (PMI) readings for Eurozone economies. This starts with the Spanish reading at 10:15 AM Egypt time, the German reading at 10:55 AM Egypt time, and the aggregate Eurozone reading at 11:00 AM Egypt time. Following this, the US ISM Manufacturing PMI reading will be announced at 5:00 PM Egypt time.

Meanwhile, attention will now turn to the peace negotiations between Ukraine and Russia. As is known, any breakthrough could push energy prices down and potentially support the euro until the end of the year.

Trading Advice:

The EUR/USD exchange rate remains in a convoluted range. We are waiting for a strong move to determine the most suitable trading opportunities. Ultimitally, Buying below 1.1480 may be the best option.

Ready to trade our daily Forex analysis? We’ve made this forex brokers list for you to check out.

Source link

1 12, 2025

Supple Unveils Exclusive Cyber Monday Deal

By |2025-12-01T18:41:20+02:00December 1, 2025|Dietary Supplements News, News|0 Comments


Today only, Supple, a 7-day fast-acting, premium joint health dietary supplement trusted by customers since 2006, is offering its final and biggest joint-support savings of the year to military personnel, veterans, law enforcement officers, firefighters, EMS professionals, and their families. With 35 percent off first-time subscriptions, 20 percent off one-time orders over $100, and free shipping on all orders over $100, it’s the perfect opportunity to stock up on premium joint health formulas trusted by those who push their bodies to the limit. Customers can enter code CYBERMONDAY2025 at checkout to secure these limited-time savings on Dec. 1, 2025.

This year’s promotions highlight Supple’s continued commitment to the men and women who serve and protect through its Supple Squad Initiative, offering easier access to clinically supported joint health products designed to help individuals maintain mobility, flexibility, and comfort at any age.

“Cyber Monday gives us one more opportunity to support the people who keep our communities and our country safe,” said Peter Apatow, Founder and CEO of Supple. “Our mission has always been to provide premium joint health supplements crafted with the highest-quality ingredients for individuals with demanding lifestyles. These savings make it easier than ever for our military members, first responders, and their families to access the support they deserve.”

Supple Drink Instant is a joint health drink mix designed to support joint comfort, mobility, and flexibility in as fast as 7 days. Made with European pharmaceutical-grade chondroitin sulfate, shellfish-free glucosamine, Boswellia serrata AKBA, vitamin C, and vitamin D3, the formula helps preserve cartilage, protect joints, and support immune health. Supple Instant delivers the same ingredients, dosages, and benefits as Supple Drink.

With over a decade of trusted use and more than 100 million cans sold, Supple Drink features the same high-purity ingredients: European pharmaceutical-grade chondroitin sulfate, shellfish-free glucosamine, Boswellia serrata AKBA, high-purity vitamin C, and vitamin D3. Designed for those who push their bodies to the limit, Supple Drink supports joint comfort, mobility, flexibility, and overall wellness in a convenient, ready-to-drink format.

Supple TurboFlex® Joint Health Supplement delivers an effective dosage of Boswellia serrata AKBA, backed by strong clinical research and medical expert review. It is formulated to support comfort, flexibility, and mobility—especially important for tactical athletes, active-duty personnel, and first responders who rely on strong, responsive joints in high-performance environments.

Designed for working dogs and service animals, Supple Pets® Hip & Joint Health Chews are made with the same premium glucosamine and chondroitin trusted in Supple’s human formulas. These chews support mobility and comfort for K9 partners who serve alongside handlers in law enforcement, military, and search-and-rescue roles.

Supple products support the physical demands placed on military members, veterans, law enforcement officers, firefighters, EMTs, and their families. Supple uses only premium, clinically supported ingredients, independently verified for purity and manufactured under FDA Good Manufacturing Practices (GMP).

This year’s holiday savings continue the company’s commitment to making high-quality joint support more accessible to those who protect and serve. Verified military members, first responders, law enforcement officers, and healthcare professionals can stack the discounts and receive an additional 20 percent off on every order placed through the Supple Squad GOVX Program. With a GOVX ID, members can instantly verify their status as military, first responder, law enforcement, or healthcare professionals and automatically unlock an additional 20 percent discount on every Supple order. Members can also receive free shipping on orders of $100 or more after discount and access savings on trusted joint health solutions.



Source link

1 12, 2025

Dogecoin Price Prediction Weakens; Remittix Attracts Growing

By |2025-12-01T18:35:11+02:00December 1, 2025|Crypto News, News|0 Comments

Dogecoin price prediction shifts are a top story after market flows moved away from meme bets into payment-linked DeFi projects. Dogecoin price prediction matters again as traders react to new liquidity trends.

The crypto market just closed one of the busiest weeks since the U.S. election cycle talks renewed rate policy fears. Federal Reserve commentary pushed dollar strength, often draining meme-driven inflows. Instead, capital momentum rotated toward practical payment-focused chains.

One rising PayFi system now leads discussion among big license partners and exchange desks. The shift sparked “miss it, regret it” psychology across community boards. This funding wave comes after the PayFi builder pulled in $28.3 million from top ICO investors.

Doge Under Pressure: Why Dogecoin Price Prediction Is Turning Softer

Dogecoin price prediction softness became clearer after whale orientation data showed slower accumulation, with some large addresses taking profit above local highs. Even the biggest meme market voice, Elon Musk, stayed quiet this week.

Removing the social spark that often pulls fresh retail volume. Dogecoin price prediction models now flag limited short-term catalysts because macro traders are focused on rate policy, CPI timing, and Bitcoin flows.

Dogecoin price prediction needs strong network use to hold price lines. But daily active addresses fell slightly week-over-week.

Dogecoin price prediction short targets moved lower as order books on centralized exchanges thinned outside major news hours. Transparency pages and payment chatter pulled attention away from mascot coins to fee-light payment rails.

Remittix: The PayFi Wallet Goes Public on Phones

This week marked a turning point. The Remittix https://remittix.io/ wallet is now live in the Apple App Store. It works as a full crypto wallet in its first phase. Users can safely save crypto, send crypto, and control private keys with clean, fast screens. Beyond meme hype, this step shows actual delivery from the PayFi team.

The PayFi wallet links crypto to bank payout rails. That detail explains why whales rotated this week as Dogecoin price prediction softened. The project raised $28.3 million in private funding before the app release. That level of demand shows deep belief in a DeFi project that pays people in stable value, not mascots.

In December, the wallet will add crypto-to-fiat features. This will let users swap crypto into normal currency inside the app. The update is planned for community delivery weeks before Christmas. Android users will also get access through the Google Play Store soon. There is also an ongoing 200% black friday bonus.

Standout Features

● Global Reach: Payouts land in 30+ countries through crypto-to-bank rails.

● Real-World Use: Built for actual payments and real money flows, not only online jokes.

● Team Cred: The team is verified by CertiK https://skynet.certik.com/projects/remittix-labs, and holds the #1 rank for pre-launch tokens on Skynet this week.

● Chain Freedom: A cross-chain DeFi system that supports many assets from day one.

● Fee Light: Low gas fee crypto design to save users money on transfers.

Table: Market Snapshot Before the Conclusion

Asset – Key Market Note – Current Mood

Dogecoin – Dogecoin price prediction weakens as whales rotate into payment rails – Cooler, cautious

Remittix (RTX) – $28.3 million private funding + wallet live + December update ahead – Busy, alert

Rotation Week Tells the Real Story

Dogecoin price prediction is weaker today because the market wants tools that move real money with low fees. Meme tokens still have fans. But November flows show a new order: payment-linked chains are pull above mascot bets when whales act. The wallet release proves the PayFi system is not theory.

Investors who track liquidity stories and fee economics may view this as a break-or-wait moment for DOGE. Whale money already turned its head. The trend favors payout over mascots. Many community voices repeated the same idea this week: missing this cycle could hurt later more than losing a quick scalp trade today.

Frequently Asked Questions

1. Why is Dogecoin price prediction weaker this week?

Because whales reduced meme exposure while macro traders focused on rate policy and Bitcoin dominance.

2. Where is the Remittix Wallet available now?

It is live on the Apple App Store for iPhone users.

3. What is the next update for Remittix?

Crypto-to-fiat payouts will be added in December.

4. Will Android users get the wallet?

Yes. Google Play Store release is already moving, and it is next.

5. Why do whales look at payment-linked DeFi projects now?

They want fee savings, bank payout pipes, and real flow stories, not only mascots.

6. Is Remittix only a meme coin?

No. It is a PayFi wallet system built for payments with cross-chain support and low gas fees.

Discover the future of PayFi with Remittix by checking out their project here:

Website: https://remittix.io

Socials: https://linktr.ee/remittix

$250, 000 Giveaway: https://gleam.io/competitions/nz84L-250000-remittix-giveaway

Disclaimer: This article is for informational purposes only and does not constitute financial advice. Cryptocurrency investments carry risk, including total loss of capital. Readers should conduct independent research and consult licensed advisors before making any financial decisions.

Crypto Press Release Distribution by https://btcpresswire.com

This release was published on openPR.

Source link

1 12, 2025

DeFi Technologies Shares Face Pressure Amid Crypto Market Sell-Off

By |2025-12-01T17:19:02+02:00December 1, 2025|News, NFT News|0 Comments


Shares of DeFi Technologies are experiencing significant downward pressure today, caught in a broad-based digital asset rout. A sharp decline in the prices of Bitcoin and Ethereum, triggered by a security breach at Yearn Finance and subsequent forced liquidations, has created a highly risk-averse environment for companies operating in the crypto asset management space.

The catalyst for today’s sector-wide slump is a reported exploit of the Yearn Finance yETH liquidity pool, which occurred this morning. While the direct financial loss for Yearn is estimated at approximately $9 million, the psychological impact on investor sentiment has been severe, casting doubt on the fragile recovery witnessed in late November.

Data from CoinGlass and Decrypt indicates the security incident set off a cascade of forced selling. The consequence was $637 to $646 million in liquidations across crypto derivatives markets within a 24-hour period. Bitcoin tumbled roughly 6 percent, falling toward the $86,000 range, while Ethereum and Solana posted even steeper losses.

For DeFi Technologies, whose subsidiary Valour issues exchange-traded products (ETPs) tracking these very assets, the impact is twofold. First, the net asset value of the company’s crypto holdings and ETPs is likely shrinking in tandem with the underlying spot prices. Second, as a proxy for crypto exposure on traditional equity markets, DeFi Technologies stock typically amplifies the volatility seen in the broader digital asset sector.


Should investors sell immediately? Or is it worth buying DeFi Technologies?

Timing Compounds Challenges for DeFi Technologies

The current market turbulence arrives at an inopportune moment for the company. Investors are still processing the third-quarter financial results released on November 14, which reported revenues of about $22.5 million and an operating profit of approximately $9 million. Although the company remained profitable, with earnings per share around $0.01, the figures fell short of some of the market’s more aggressive expectations.

On a positive note, the firm recently secured strategic approval for QCAD, a Canadian dollar stablecoin, to be used on its payment rails, an announcement made on November 26. However, enthusiasm surrounding this infrastructure development is currently being overshadowed by the sector-wide liquidity crisis.

Key Technical Levels to Monitor

Market participants should brace for continued volatility in DeFi Technologies’ share price as U.S. markets digest the full extent of the crypto leverage unwinding.

Critical factors for traders to watch include:

  • Bitcoin’s Price Floor: Failure for BTC to maintain support above the $85,000 level would likely invite further selling pressure on DEFT shares.
  • Arbitrage Opportunities: The company’s DeFi Alpha trading desk generally benefits from elevated market volatility and widening spreads.
  • Share Price Support: Analysts are eyeing the $1.40 to $1.50 range as a critical support zone; a sustained break below this level could signal a deeper correction is underway.

Ad

DeFi Technologies Stock: Buy or Sell?! New DeFi Technologies Analysis from December 1 delivers the answer:

The latest DeFi Technologies figures speak for themselves: Urgent action needed for DeFi Technologies investors.
Is it worth buying or should you sell? Find out what to do now in the current free analysis from December 1.

DeFi Technologies: Buy or sell?

Read more here…



Source link

1 12, 2025

At a Major Crossroads (Chart)

By |2025-12-01T16:46:01+02:00December 1, 2025|Forex News, News|0 Comments

  • The British pound traded quietly amid thin post-Thanksgiving conditions, with major technical levels clustering near 1.32.
  • A decisive break on either side of this inflection zone could determine the broader trend in the weeks ahead.

The British pound has been somewhat noisy during the trading session on Friday as we continue to see a lot of technical factors come into the picture. Friday, of course, was a fairly quiet trading session due to the fact that although the Thanksgiving holiday was over, it’s generally accepted that most Americans don’t go back to work until Monday. So, because of this, you have an entire part of the world that isn’t even involved in the markets.

That being said, it’s worth noting that the technical confluence is worth paying close attention to because it could matter. The 200-day EMA, the 50-day EMA, and the 1.32 level all come into play in this general vicinity. And if we break down below the 1.32 level, then I think we’ve got a situation where the market just simply rejected breaking above these crucial moving averages and broke above the idea of changing trends.

Critical Inflection Levels

If we drop from here, we could go to the 1.30 level given enough time. On the other hand, if we turn around and break above the 1.33 level, then we could go looking to the 1.35 level. But in that environment, I would expect not only the British pound to do fairly well against the US dollar, but multiple other currencies well, including the euro and the Canadian dollar.

In general, the British pound has made a massive topping pattern for most of the year. And now we are at a major point of inflection that will probably determine where we go for the next several weeks. Federal Reserve interest rate cut expectations continue to be very noisy. And it’s worth noting that the market keeps fluctuating between an almost guaranteed rate cut to a lot of questions asked about that.

And it has a major influence on the US dollar.

Keep in mind that the Bank of England almost cut interest rates last time, and the vote count only reinforced the idea that perhaps the rate cuts are coming fairly soon. Now the question is how many times will they cut? I think this is a market that probably continues to be very noisy as both central banks are in play at the moment.

Ready to trade our daily Forex GBP/USD analysis? We’ve made this UK forex brokers list for you to check out.

Source link

1 12, 2025

Understanding tea’s health benefits and risks

By |2025-12-01T16:40:04+02:00December 1, 2025|Dietary Supplements News, News|0 Comments


The review confirms that tea, particularly green tea, plays a crucial role in preventing cardiovascular diseases (CVDs), obesity, diabetes, and certain types of cancer. Tea’s neuroprotective effects, ability to reduce muscle loss in seniors, and its anti-inflammatory and antimicrobial activities further highlight its potential health-promoting properties. However, the study also identifies potential health concerns, particularly with bottled and bubble teas, which may contain harmful additives like artificial sweeteners and preservatives.

Tea, made from the leaves of Camellia sinensis, has been consumed globally for centuries, initially for its medicinal properties and later as a popular beverage. It has long been recognized for its rich polyphenolic content, particularly catechins, which contribute to its health benefits. This review aims to provide a detailed analysis of tea’s impact on various health conditions, supported by both experimental and human studies. Despite extensive studies on green tea, there is limited information on the effects of other tea types, such as black, oolong, and white tea, especially concerning their comparative health benefits. Furthermore, the health concerns raised by the presence of additives and contaminants in some commercial tea beverages are addressed.

A study (DOI: 10.48130/bpr-0025-0036) published in Beverage Plant Research on 13 November 2025 by Mingchuan Yang & Li Zhou’s team, Tea Research Institute, Chinese Academy of Agricultural Sciences, underlines the need for further research to better understand tea’s health benefits and risks.

The review delves into various health conditions linked to tea consumption. Green tea is highlighted for its cardiovascular protective effects, reducing blood pressure and improving cholesterol levels. Multiple cohort studies also show that regular tea consumption can lower the risk of all-cause mortality, CVDs, and certain cancers. Furthermore, tea’s role in weight management and its potential in controlling diabetes are discussed, with evidence suggesting that green tea catechins can aid in weight reduction and improve metabolic parameters in obese individuals. Notably, tea also shows promise in neuroprotection and muscle mass preservation. Studies indicate that regular tea drinkers experience a reduced prevalence of cognitive decline and Alzheimer’s disease biomarkers, particularly in older adults. Similarly, tea catechins may prevent muscle loss in seniors, contributing to better physical performance and muscle strength. However, while tea has numerous benefits, commercial tea products such as bottled or bubble tea, often contain sugar, artificial sweeteners, and preservatives, which may reduce or negate the health benefits. Additionally, concerns regarding pesticide residues, heavy metals, and microplastics in tea have been raised. These contaminants, though not posing significant health risks in typical consumption, remain a concern for long-term heavy tea drinkers. Moreover, the review addresses the issue of nutrient absorption interference, specifically with non-heme iron and calcium, potentially affecting people on vegetarian diets or those with specific nutritional needs.

The health benefits of tea are clear, but its consumption in processed forms like bottled tea and bubble tea should be moderated due to added sugars and preservatives. The findings from this review suggest that moderate consumption of traditional, freshly brewed tea can be beneficial, especially for preventing cardiovascular diseases, diabetes, and cancer. Future studies focusing on the long-term health effects of different tea types and the impact of contaminants will help refine our understanding of tea’s health benefits and risks.

Source:

Journal reference:

Yang, M., et al. (2025). Beneficial health effects and possible health concerns of tea consumption: a review. Beverage Plant Research. doi: 10.48130/bpr-0025-0036. https://www.maxapress.com/article/doi/10.48130/bpr-0025-0036



Source link

Go to Top